v3.26.1
Revenue from Contracts with Customers - Summary of Disaggregation of Revenues by Major Revenue Streams (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Total revenue $ 17,258 $ 16,544 $ 15,846
Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 14,605 14,050 12,979
Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 678 [1] 173 [2] 681 [3]
Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,551 1,576 1,615
Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 423 [4] 745 [5] 570 [6]
International Markets [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 2,162 2,463 2,351
International Markets [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 2,039 2,280 2,229
International Markets [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 28 [1] 24 [2] 28 [3]
International Markets [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 54 39 38
International Markets [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 41 [4] 121 [5] 57 [6]
Other Activities [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 2,365 2,480 2,503
Other Activities [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 526 553 565
Other Activities [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 4 [1] 11 [2] 5 [3]
Other Activities [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,496 1,536 1,577
Other Activities [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 339 [4] 380 [5] 357 [6]
United States [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 7,690 6,498 6,154
United States [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 7,081 6,327 5,554
United States [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 607 [1] 103 [2] 597 [3]
United States [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 0 0 0
United States [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 2 [4] 68 [5] 2 [6]
Europe [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 5,040 5,103 4,837
Europe [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 4,959 4,891 4,631
Europe [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 39 [1] 35 [2] 51 [3]
Europe [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1 1  
Europe [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue $ 41 [4] $ 176 [5] $ 155 [6]
[1] Revenues from licensing arrangements in United States segment were mainly comprised of development milestone payments of $500 million received in the fourth quarter of 2025, in connection with the initiation of Phase 3 studies for duvakitug (anti-TL1A). See note 2.
[2] “Other” revenues in all segments include revenues related to sales of certain product rights.
[3] Revenues from licensing arrangements in United states segment were mainly comprised of $500 million upfront payment received in connection with the collaboration on Teva’s anti-TL1A asset. See note 2.
[4] “Other” revenues in Europe and International Markets segments include revenues related to sales of certain product rights.
[5] “Other” revenues in United States, Europe and International Markets segments include revenues related to sales of certain product rights.
[6] “Other” revenues in Europe segment mainly related to the sale of certain product rights.